Compare Precision System Science Co., Ltd. with Similar Stocks
Dashboard
1
With a growth in Net Profit of 38.33%, the company declared Very Positive results in Jun 26
- The company has declared positive results for the last 8 consecutive quarters
- ROCE(HY) Highest at 10.06%
- INVENTORY TURNOVER RATIO(HY) Highest at 2.48 times
- DIVIDEND PAYOUT RATIO(Y) Highest at 28.42%
2
With ROE of 4.16%, it has a expensive valuation with a 1.34 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
JPY 5,727 Million (Micro Cap)
32.00
NA
0.00%
-0.01
4.16%
1.47
Revenue and Profits:
Net Sales:
1,438 Million
(Quarterly Results - Jun 2026)
Net Profit:
193 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
11.05%
0%
11.05%
6 Months
-5.8%
0%
-5.8%
1 Year
1.44%
0%
1.44%
2 Years
-24.37%
0%
-24.37%
3 Years
-31.94%
0%
-31.94%
4 Years
-51.38%
0%
-51.38%
5 Years
-69.55%
0%
-69.55%
Precision System Science Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-10.15%
EBIT Growth (5y)
-33.38%
EBIT to Interest (avg)
-9.89
Debt to EBITDA (avg)
1.94
Net Debt to Equity (avg)
-0.18
Sales to Capital Employed (avg)
0.87
Tax Ratio
5.09%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.56%
ROE (avg)
2.77%
Valuation key factors
Factor
Value
P/E Ratio
32
Industry P/E
Price to Book Value
1.34
EV to EBIT
53.15
EV to EBITDA
16.29
EV to Capital Employed
1.34
EV to Sales
1.03
PEG Ratio
0.23
Dividend Yield
NA
ROCE (Latest)
2.52%
ROE (Latest)
4.16%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
1,438.40
1,244.10
15.62%
Operating Profit (PBDIT) excl Other Income
118.90
105.20
13.02%
Interest
5.20
4.70
10.64%
Exceptional Items
0.00
0.00
Consolidate Net Profit
193.30
139.70
38.37%
Operating Profit Margin (Excl OI)
46.50%
39.90%
0.66%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is 15.62% vs 2.20% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is 38.37% vs 1,762.67% in Mar 2026
Annual Results Snapshot (Consolidated) - Jun'26
Jun'26
Jun'25
Change(%)
Net Sales
5,216.90
4,692.60
11.17%
Operating Profit (PBDIT) excl Other Income
409.00
116.60
250.77%
Interest
16.80
20.50
-18.05%
Exceptional Items
-3.60
-113.10
96.82%
Consolidate Net Profit
394.90
-253.10
256.03%
Operating Profit Margin (Excl OI)
38.60%
-25.90%
6.45%
USD in Million.
Net Sales
YoY Growth in year ended Jun 2026 is 11.17% vs 17.90% in Jun 2025
Consolidated Net Profit
YoY Growth in year ended Jun 2026 is 256.03% vs 77.43% in Jun 2025
About Precision System Science Co., Ltd. 
Precision System Science Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






